It's quite crafty of Heddle, as far as these types of
It's quite crafty of Heddle, as far as these types of things go.
Making a gigantic personal loan to the company certainly seems like a strong endorsement.
Anyone who was still willing to step up and invest more in the company would have done so after Heddle made that loan. After all, why would a "successful businessman" make a loan of that magnitude unless he was sure of success?
And then two years later, we find out that he likely paid himself all of that money, and more, through a sneaky maneuver, leaving the company penniless. This was clearly done in such a way as to give the misleading impression that Heddle still has millions of dollars of his own money at risk.
And as you point out, the debt owed by PTOI to Heddle continues to pile up. Heddle will end up having made quite a pretty penny on a failed company when all is said and done.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...
Continue Reading
Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...
Continue Reading
Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...
Continue Reading
Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...
Continue Reading
Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...
Continue Reading